There’s a care model for schizophrenia that actually works—why isn’t it everywhere? On this episode, W. Gordon Frankle, MD, MBA, Vice Chair of Psychiatry at NYU Langone Health, shares how his team in Brooklyn is building a new model for treating serious mental illness—one rooted in long-term, relationship-driven, team-based care. From wraparound services to precision psychiatry, this conversation explores what happens when you bring humanity, structure, and innovation to a population too often left behind.Also discussed:The first novel schizophrenia drug in over 50 years (Cobenfy)Why clozapine is underused—and how that may finally changeThe potential of brain imaging and biomarkers in psychiatric treatmentWhat a real community mental health system looks likeWhy trust, not just treatment, is essential for recovery🔍 Topics Covered00:00 Introduction00:30 Dr. Frankle's Current Work01:08 Advancements in Schizophrenia Research02:29 Challenges and New Treatments in Schizophrenia05:02 Precision Medicine in Psychiatry05:59 PET Scans and Brain Energetics09:46 Barriers to Effective Treatment11:51 Clozapine and Treatment Access13:38 Wraparound Services and Community Care14:46 Early Screening and Public Health Interventions18:32 Mandated Treatment and Patient Engagement30:08 Homelessness and Mental Health34:54 Future Directions in Schizophrenia Treatment38:09 Conclusion📚 Related ResourcesW. Gordon Frankle, MD, MBA Schizophrenia care at NYU Langone NYU Langone Hospital—Brooklyn 3 Things to Know About Cobenfy (Yale Medicine) 🙌 Support & EngageIf you enjoyed this episode, please like, share, and subscribe to support real conversations about transforming mental health care.Visit our website for more Insights on Psychiatry.Watch this episode on YouTubeExecutive Producer: Jon Earle

Ver todos los episodios